tada ... Good summary, always enjoy your posts. I agree that based on the potential, $1b is miniscule compared to the potential value "if" we ever get the next trials funded and actually started AND "if" we actually get good results that prove statistically significant efficacy. I really don't doubt the science, just whether those "if's" will ever occur ... but still optimistic, hopeful, and long on the stock despite the negativity.

I think the $1b notion is more based on not finding an affordable partner for ongoing studies, and we have to punt. Hopefully the $1b would be the floor, based on all that has been achieved with the science and IP, patents, BTD, ad hoc data, etc. Hopeful for a lot more based on the potential, but $1b and likely somewhere between $3-4 dollars per share would be "achievable" among a few bidding interested BP's, ... in the worst case scenario of being faced with insolvency and turning out the lights.

I think that was more the point of the $1b thought exercise, rather than "real" potential value, but not sure?